Abstract:Recent studies have demonstrated a role for Ten-Eleven Translocation-2 (TET2), an epigenetic modulator, in regulating germinal center formation and plasma cell differentiation in B-2 cells, yet the role of TET2 in regulating B-1 cells is largely unknown. Here, B-1 cell subset numbers, IgM production, and gene expression were analyzed in mice with global knockout of TET2 compared to wildtype (WT) controls. Results revealed that TET2-KO mice had elevated numbers of B-1a and B-1b cells in their primary niche, the peritoneal cavity, as well as in the bone marrow (B-1a) and spleen (B-1b). Consistent with this finding, circulating IgM, but not IgG, was elevated in TET2-KO mice compared to WT. Analysis of bulk RNASeq of sort purified peritoneal B-1a and B-1b cells revealed reduced expression of heavy and light chain immunoglobulin genes, predominantly in B-1a cells from TET2-KO mice compared to WT controls. As expected, the expression of IgM transcripts was the most abundant isotype in B-1 cells. Yet, only in B-1a cells there was a significant increase in the proportion of IgM transcripts in TET2-KO mice compared to WT. Analysis of the CDR3 of the BCR revealed an increased abundance of replicated CDR3 sequences in B-1 cells from TET2-KO mice, which was more clearly pronounced in B-1a compared to B-1b cells. V-D-J usage and circos plot analysis of V-J combinations showed enhanced usage of V H 11 and V H 12 pairings. Taken together, our study is the first to demonstrate that global loss of TET2 increases B-1 cell number and IgM production and reduces CDR3 diversity, which could impact many biological processes and disease states that are regulated by IgM.

Publisher Correction: Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity

Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

Publisher Correction: the Transcriptional Coactivator TAZ Regulates Reciprocal Differentiation of TH17 Cells and Treg Cells.

Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression

Author Correction: T cell–encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection

Publisher Correction: The transcriptional cofactor Tle3 reciprocally controls effector and central memory CD8 + T cell fates

Correction: Antigen-presenting Autoreactive B Cells Activate Regulatory T Cells and Suppress Autoimmune Arthritis in Mice

Correction: Retraction: Arid3b Is Critical for B Lymphocyte Development

Erratum: Themis, a T Cell–specific Protein Important for Late Thymocyte Development

Author Correction: BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells

Corrigendum: Cytosolic protein translation regulates cell asymmetry and function in early TCR activation of human CD8+ T lymphocytes

Erratum: Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease

Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation

Author Correction: Specific CD4 + T cell phenotypes associate with bacterial control in people who 'resist' infection with Mycobacterium tuberculosis

TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells

Loss of TET2 increases B-1 cell number and IgM production while limiting CDR3 diversity

Erratum: Corrigendum: Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program

TET2 Promotes Anti-Tumor Immunity by Governing G-MDSCs Andcd8+t-Cell Numbers

Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours

Publisher Correction: A protein assembly mediates Xist localization and gene silencing

Author Correction: IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting